Cascorbi I - Search Results

1

Werk AN, Cascorbi I. Werk AN, et al. Among authors: cascorbi i. Clin Pharmacol Ther. 2014 Sep;96(3):340-8. doi: 10.1038/clpt.2014.129. Epub 2014 Jun 13. Clin Pharmacol Ther. 2014. PMID: 24926778 Review.

2

Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearance.

Werk AN, Lefeldt S, Bruckmueller H, Hemmrich-Stanisak G, Franke A, Roos M, Küchle C, Steubl D, Schmaderer C, Bräsen JH, Heemann U, Cascorbi I, Renders L. Werk AN, et al. Among authors: cascorbi i. Clin Pharmacol Ther. 2014 Apr;95(4):416-22. doi: 10.1038/clpt.2013.210. Epub 2013 Oct 14. Clin Pharmacol Ther. 2014. PMID: 24126681

3

HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury.

Nicoletti P, Werk AN, Sawle A, Shen Y, Urban TJ, Coulthard SA, Bjornsson ES, Cascorbi I, Floratos A, Stammschulte T, Gundert-Remy U, Nelson MR, Aithal GP, Daly AK; International Drug-induced Liver Injury Consortium. Nicoletti P, et al. Among authors: cascorbi i. Pharmacogenet Genomics. 2016 May;26(5):218-24. doi: 10.1097/FPC.0000000000000209. Pharmacogenet Genomics. 2016. PMID: 26959717

4

Influence of CYP3A4, CYP3A5, and ABCB1 genotype and expression on budesonide pharmacokinetics: a possible role of intestinal CYP3A4 expression.

Ufer M, Dilger K, Leschhorn L, Daufresne L, Mosyagin I, Rosenstiel P, Haesler R, Kuehbacher T, Nikolaus S, Schreiber S, Cascorbi I. Ufer M, et al. Among authors: cascorbi i. Clin Pharmacol Ther. 2008 Jul;84(1):43-6. doi: 10.1038/sj.clpt.6100505. Epub 2008 Mar 5. Clin Pharmacol Ther. 2008. PMID: 18322448

5

Progress in pharmacogenomics: bridging the gap from research to practice.

Cascorbi I, Tyndale R. Cascorbi I, et al. Clin Pharmacol Ther. 2014 Mar;95(3):231-5. doi: 10.1038/clpt.2013.235. Clin Pharmacol Ther. 2014. PMID: 24548984

6

Pharmacogenomic or -epigenomic biomarkers in drug treatment: Two sides of the same medal?

Ingelman-Sundberg M, Cascorbi I. Ingelman-Sundberg M, et al. Among authors: cascorbi i. Clin Pharmacol Ther. 2016 May;99(5):478-80. doi: 10.1002/cpt.351. Epub 2016 Mar 29. Clin Pharmacol Ther. 2016. PMID: 26874931

7

CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients.

Renders L, Frisman M, Ufer M, Mosyagin I, Haenisch S, Ott U, Caliebe A, Dechant M, Braun F, Kunzendorf U, Cascorbi I. Renders L, et al. Among authors: cascorbi i. Clin Pharmacol Ther. 2007 Feb;81(2):228-34. doi: 10.1038/sj.clpt.6100039. Epub 2006 Dec 27. Clin Pharmacol Ther. 2007. PMID: 17192769 Clinical Trial.

8

ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics?

Cascorbi I. Cascorbi I. Clin Pharmacol Ther. 2010 Jan;87(1):15-8. doi: 10.1038/clpt.2009.237. Clin Pharmacol Ther. 2010. PMID: 20019695 Review. No abstract available.

9

Pharmacological treatment of pain: future trends and novel insights.

Cascorbi I. Cascorbi I. Clin Pharmacol Ther. 2015 Feb;97(2):104-8. doi: 10.1002/cpt.25. Clin Pharmacol Ther. 2015. PMID: 25670508

10

Epigenetics in Drug Response.

Cascorbi I, Schwab M. Cascorbi I, et al. Clin Pharmacol Ther. 2016 May;99(5):468-70. doi: 10.1002/cpt.349. Clin Pharmacol Ther. 2016. PMID: 27061003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page